Fundraising Fox

Cagent Vascular

Wayne, US · Founded 2014 · Delaware corporation · 2 known investors

cagentvascular.com ↗

Cagent Vascular develops the Serranator, a balloon angioplasty device that uses serration remodeling therapy to gently remodel blood vessels and restore blood flow. The company targets vascular surgeons and interventional radiologists for the treatment of cardiovascular disease.

HealthtechMedical Devicesin /cagent-vascular

Founders & leadership

BB
Bruce Brumfield, Jr.Director
AG
Aaron GreeninSecretary of Issuer
MM
Marc-Andre MarcotteDirector
TC
Tak CheungDirector
BW
Brian WalshinPresident of Issuer
PS
Peter SchneiderDirector
CA
Carol A. BurnsExecutive Officer, Director
RG
Robert GiasolliDirector
FL
Fred LampropoulosDirector
DM
Dennis McGrathExecutive Officer, Director
CT
Casey TanseyDirector

Investors · 2

US Venture PartnersMenlo Park · $500K – $10Mvia Casey Tansey · board
Astoria Health InvestorsreportedLas Vegas

Reported raises · per SEC filings

Form D private placements
▶$24.5MraisedJun 2026 · 51 investors · Other Health Care
Rule 506(b)
Cagent Vascular has raised $41 Million in new Series D Funding - intelligence360intelligence360.news · Jun 2026Cagent Vascular Raises $41 Million to Advance IVL Platform - MyChesComychesco.com · Jun 2026
Officers, directors & promoters on the filing
  • Bruce Brumfield, Jr.Director
  • Casey TanseyDirector
  • Aaron GreenExecutive Officer
  • Marc-Andre MarcotteDirector
  • Tak CheungDirector
  • Brian WalshExecutive Officer, Director
Offering amount
$41M
Amount sold
$24.5M
First sale
May 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$28.7MraisedFeb 2024 · 26 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian WalshDirector
  • Dennis McGrathExecutive Officer
  • Casey TanseyDirector
  • Marc-Andre MarcotteDirector
  • Bruce J BlumfieldDirector
  • Carol A. BurnsExecutive Officer, Director
Offering amount
$30.3M
Amount sold
$28.7M
First sale
Jan 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.2MraisedMay 2023 · 41 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Brian WalshDirector
  • Greg FreddeDirector
  • Dennis McGrathExecutive Officer, Director
  • Mike MarkertDirector
  • Carol BurnsExecutive Officer, Director
  • Peter SchneiderDirector
  • Marc-Andre MarcotteDirector
Offering amount
$11M
Amount sold
$7.2M
First sale
Apr 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.5MraisedJun 2021 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Carol BurnsExecutive Officer, Director
  • Mike MarkertDirector
  • Peter SchneiderDirector
  • Brian WalshDirector
  • Dennis McGrathExecutive Officer, Director
  • Marc-Andre MarcotteDirector
  • Fred LampropoulosDirector
Offering amount
$9.5M
Amount sold
$9.5M
First sale
Jun 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedMay 2018 · 31 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter SchneiderDirector
  • Carol A. BurnsExecutive Officer, Director
  • Brian WalshDirector
  • Robert GiasolliDirector
  • Fred LampropoulosDirector
  • Dennis McGrathExecutive Officer, Director
Offering amount
$12M
Amount sold
$3M
First sale
Jul 2017
Incorporated
Limited Liability Company, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news